EUVIMEDEUVIMED entdecken
Open Access

Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer

Hiroo Suto, A N Fujita, Hibiki Sakai, Marin Muramatsu, Ryosuke Wakamatsu, Ayaka Wakamatsu, Miki Katsuragawa, Mitsugu Tanaya, Kazuya Hiura

In Vivo · 2026

DOI: 10.21873/invivo.14459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Hiroo Suto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Pharmacy, Asahikawa Kosei General Hospital, Asahikawa, Japan. Hauptthemen laut MEDLINE: Tegafur, Oxonic Acid, Pancreatic Neoplasms, Nutritional Status. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Maintaining treatment intensity is important during adjuvant S-1 chemotherapy for resectable pancreatic cancer; however, factors associated with reduced relative dose intensity (RDI) during adjuvant chemotherapy (AC) remain unclear. This study investigated the association between perioperative inflammatory and nutritional indices and the RDI of S-1 during AC. PATIENTS AND METHODS: This retrospective single-center study included 69 patients with resectable pancreatic cancer who underwent adjuvant S-1 chemotherapy following neoadjuvant chemotherapy (NAC) and pancreatectomy between November 2019 and February 2025. Patients were classified according to AC S-1 RDI (≥80% vs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TegafurOxonic AcidPancreatic NeoplasmsNutritional StatusHumansFemaleMaleAgedDrug CombinationsChemotherapy, AdjuvantPrognosisMiddle AgedRetrospective StudiesNutrition AssessmentPancreatectomyNeoadjuvant Therapy

Stichwörter der Autor:innen

Pancreatic neoplasmsS-1adjuvantchemotherapygeriatric nutritional risk indexrelative dose intensity

Substanzen

TegafurOxonic AcidS 1 (combination)Drug Combinations

Autor:innen und Institutionen

  • Hospital Pharmacy, Asahikawa Kosei General Hospital, Asahikawa, Japan.
  • Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan.
  • Hospital Pharmacy, Sapporo Kosei General Hospital, Sapporo, Japan.
  • Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan; hiura-k@hus.ac.jp.

Zitieren

APA

Suto, H., Fujita, A. N., Sakai, H., Muramatsu, M., Wakamatsu, R., Wakamatsu, A., Katsuragawa, M., Tanaya, M., & Hiura, K. (2026). Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer. In Vivo. https://doi.org/10.21873/invivo.14459

Vancouver

Suto H, Fujita AN, Sakai H, Muramatsu M, Wakamatsu R, Wakamatsu A, et al. Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer. In Vivo. 2026. doi:10.21873/invivo.14459

BibTeX
@article{Suto2026,
  author = {Suto, Hiroo and Fujita, A N and Sakai, Hibiki and Muramatsu, Marin and Wakamatsu, Ryosuke and Wakamatsu, Ayaka and Katsuragawa, Miki and Tanaya, Mitsugu and Hiura, Kazuya},
  title = {Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer},
  journal = {In Vivo},
  year = {2026},
  doi = {10.21873/invivo.14459}
}
Kostenlos starten →